– Health care as an industry will only continue to grow and offers an exceptional place to invest. Drug stocks face a historically high chance of failure, but medical devices are an attractive addition for investors wanting exposure to this booming market, up 440% over last few years.
– Biotricity (BTCY) just received FDA clearance for a new cardiomonitoring device and will be launching the product this year into a multi-billion dollar market with just a few competitors. With more devices planned for 2018 and 2019, this could be the next big multi-bagger winner among small medical device companies.
Developing new drugs is difficult, and most drugs will never make it to the market. Just about 1 in 10 drugs that go into human testing will ever actually be approved, thus the odds are stacked against investors betting on the publicly traded …View the full post at: Unknown BTCY May Have Big Upside Ahead of Likely Near-Term FDA Approval …
Related Articles:
The Best Places In The World To Mine Bitcoin
Congress Stands Up to DEA, in Defense of Safe, Effective CBD
New Fertilizer Giant Nutrien to Keep Its Headquarters in Saskatchewan
Standard Lithium: The Three A’s of Lithium and Fast-Tracking the Cycle Explained
